PAA 0.00% 20.0¢ pharmaust limited

Ann: Board Changes, page-180

  1. 1,072 Posts.
    lightbulb Created with Sketch. 87
    Hi Pete, just a few extra bits of info ….

    Relyvrio, were on track for 10,000 patient level in the USA. They reached approx 1/3 of that.

    The annual price was approx us$160,000 per patient.

    Thats us$1.6b revenue annually.

    I think you’re undercooking it a bit, put the risk / chance of success in the discount rate or multiple, not on the cash flows.

    However, great initiative & thx, all indications point to significant value accretion, we’re only arguing over magnitude.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
0.000(0.00%)
Mkt cap ! $97.22M
Open High Low Value Volume
20.0¢ 20.0¢ 19.5¢ $244.3K 1.244M

Buyers (Bids)

No. Vol. Price($)
1 100000 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 257206 7
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.